Risankizumab-induced red face: a unique presentation

Ital J Dermatol Venerol. 2024 Jun;159(3):366-367. doi: 10.23736/S2784-8671.24.07828-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal* / adverse effects
  • Erythema / chemically induced
  • Female
  • Humans
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy

Substances

  • risankizumab
  • Antibodies, Monoclonal